Table 2 Changes in blood parameters at baseline and 12 weeks
|  |  | Exercise Group (n = 15) | Control Group (n = 14) |  p -value (Interaction) |
|---|---|---|---|---|
Triacylglycerol (mmol/L) | Baseline | 1.1 ± 0.2 | 1.0 ± 0.1 | 0.362 |
12 weeks | 1.2 ± 0.1 | 1.3 ± 0.1 | ||
TC (mmol/L) | Baseline | 3.8 ± 0.2 | 3.8 ± 0.1 | 0.108 |
12 weeks | 4.0 ± 0.2 | 4.3 ± 0.2 | ||
HDL-C (mmol/L) | Baseline | 1.1 ± 0.1 | 1.2 ± 0.1 | 0.379 |
12 weeks | 1.4 ± 0.1 | 1.4 ± 0.1 | ||
LDL-C (mmol/L) | Baseline | 2.3 ± 0.2 | 2.3 ± 0.1 | 0.282 |
12 weeks | 2.4 ± 0.1 | 2.5 ± 0.1 | ||
Glucose (mmol/L) | Baseline | 4.2 ± 0.2 | 4.5 ± 0.1 | 0.805 |
12 weeks | 4.2 ± 0.1 | 4.6 ± 0.1 | ||
Insulin (pmol/L) | Baseline | 10.3 ± 1.0 | 12.8 ± 1.8 | 0.957 |
12 weeks | 10.9 ± 1.1 | 13.3 ± 0.9 | ||
Adiponectin (ng/mL) | Baseline | 14380 ± 1290 | 12558 ± 385 | 0.293 |
12 weeks | 15950 ± 1731 | 12704 ± 457 | ||
hs-CRP (mg/dL) | Baseline | 0.16 ± 0.04 | 0.19 ± 0.07 | 0.143 |
12 weeks | 0.14 ± 0.03 | 0.07 ± 0.01 | ||
sE-selectin (ng/mL) | Baseline | 50 ± 2 | 46 ± 2 | 0.001 |
12 weeks | 49 ± 2 | 53 ± 2 | ||
VEGF (pg/mL) | Baseline | 86 ± 14 | 126 ± 17 | 0.029 |
12 weeks | 152 ± 20 | 120 ± 17 | ||
NO (μM) | Baseline | 8.1 ± 0.6 | 9.5 ± 0.6 | 0.001 |
12 weeks | 10.6 ± 1.0 | 7.0 ± 0.3 |